BOSUTINIB for Neoplasm malignant: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 59 adverse event reports in the FDA FAERS database where BOSUTINIB was used for Neoplasm malignant.
Most Reported Side Effects for BOSUTINIB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Diarrhoea | 1,820 | 23.4% | 76 | 324 |
| Nausea | 886 | 11.4% | 31 | 165 |
| Fatigue | 626 | 8.1% | 33 | 136 |
| Vomiting | 469 | 6.0% | 27 | 122 |
| Death | 465 | 6.0% | 459 | 62 |
| Rash | 426 | 5.5% | 7 | 70 |
| Pleural effusion | 398 | 5.1% | 20 | 160 |
| Neoplasm progression | 376 | 4.8% | 34 | 44 |
| Dyspnoea | 319 | 4.1% | 20 | 133 |
| Headache | 283 | 3.6% | 8 | 55 |
| Drug intolerance | 277 | 3.6% | 6 | 24 |
| Malaise | 272 | 3.5% | 12 | 68 |
| Off label use | 265 | 3.4% | 13 | 46 |
| Abdominal pain | 234 | 3.0% | 12 | 67 |
| Arthralgia | 218 | 2.8% | 5 | 47 |
Other Indications for BOSUTINIB
Chronic myeloid leukaemia (4,231)
Product used for unknown indication (350)
Leukaemia (191)
Philadelphia positive chronic myeloid leukaemia (101)
Acute lymphocytic leukaemia (89)
Myeloid leukaemia (83)
Chronic myeloid leukaemia (in remission) (56)
Philadelphia chromosome positive (53)
Acute myeloid leukaemia (50)
Chronic lymphocytic leukaemia (36)
Other Drugs Used for Neoplasm malignant
PALBOCICLIB (1,996)
CAPECITABINE (1,493)
PEMBROLIZUMAB (1,135)
PACLITAXEL (984)
CARBOPLATIN (977)
NIVOLUMAB (947)
OXALIPLATIN (823)
PAZOPANIB (716)
CYCLOPHOSPHAMIDE (685)
FLUOROURACIL (676)